Codion, Mylene S.
HRN: 11-15-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2025
CEFTRIAXONE 1G (VIAL)
03/26/2025
04/02/2025
IV
2g
Q 24H
Multiple Soft Tissue Injuries, Head, Face, Extremities, Ant Chest
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes